Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists

被引：104

作者：

Zarrinmayeh, H ^{[1
]}

Zimmerman, DM ^{[1
]}

Cantrell, BE ^{[1
]}

Schober, DA ^{[1
]}

Bruns, RF ^{[1
]}

Gackenheimer, SL ^{[1
]}

Ornstein, PL ^{[1
]}

Hipskind, PA ^{[1
]}

Britton, TC ^{[1
]}

Gehlert, DR ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 05期

关键词：

D O I：

10.1016/S0960-894X(99)00082-7

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of benzimidazoles (4) was synthesized and evaluated in vitro as potent and selective NPY Y1 receptor antagonists. Substitution of the piperidine nitrogen of 4 with appropriate R groups resulted in compounds with more than 80-fold higher affinity at the Y1 receptor compared to the parent compound 5 (R = H). The most potent benzimidazole in this series was 21 (K-i = 0.052 nM). (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：647 / 652

页数：6

共 50 条

[21] Dimeric argininamide-type neuropeptide Y receptor antagonists: Chiral discrimination between Y1 and Y4 receptors
Keller, Max
Kaske, Melanie
Holzammer, Tobias
Bernhardt, Guenther
Buschauer, Armin
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (21) : 6303 - 6322
[22] Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists
Leslie, Colin P.
Bentley, Jonathan
Biagetti, Matteo
Contini, Stefania
Di Fabio, Romano
Donati, Daniele
Genski, Thorsten
Guery, Sebastien
Mazzali, Angelica
Merlo, Giancarlo
Pizzi, Domenica A.
Sacco, Fabiola
Seri, Catia
Tessari, Michela
Zonzini, Laura
Caberlotto, Laura
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (20) : 6103 - 6107
[23] Localization of neuropeptide Y Y1 receptor mRNA human tooth pulp
Uddman, R
Kato, J
Cantera, L
Edvinsson, L
ARCHIVES OF ORAL BIOLOGY, 1998, 43 (05) : 389 - 394
[24] Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status
Moreno-Herrera, Antonio
Garcia, Abraham
Palos, Isidro
Rivera, Gildardo
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2014, 14 (11) : 896 - 919
[25] A potent nonpeptide neuropeptide Y Y1 receptor antagonist, a benzodiazepine derivative
Shigeri, Y
Ishikawa, M
Ishihara, Y
Fujimoto, M
LIFE SCIENCES, 1998, 63 (11) : PL151 - PL160
[26] The anorexia of aging: Possible involvement of neuropeptide Y receptor subtype Y1
Job, JD
Horwitz, BA
Hernandez, EJ
Landerholm, T
Craig-Veight, C
McDonald, RB
FASEB JOURNAL, 2001, 15 (05): : A981 - A981
[27] Changes in the expression of the Y1 receptor of neuropeptide Y induced by photic injury
Torbidoni, AV
Possidente, MP
Soler, MVC
Hökfelt, T
Villar, MJ
Suburo, AM
JOURNAL OF NEUROCHEMISTRY, 2001, 78 : 133 - 133
[28] Neuropeptide Y Y1 receptor modulates microglia activation in the rat retina
Ambrosio, A.
Elvas, F.
Madeira, M. H.
Martins, T.
Cavadas, C.
Santiago, A. R.
GLIA, 2015, 63 : E359 - E360
[29] Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor
Zhenlin Yang
Shuo Han
Max Keller
Anette Kaiser
Brian J. Bender
Mathias Bosse
Kerstin Burkert
Lisa M. Kögler
David Wifling
Guenther Bernhardt
Nicole Plank
Timo Littmann
Peter Schmidt
Cuiying Yi
Beibei Li
Sheng Ye
Rongguang Zhang
Bo Xu
Dan Larhammar
Raymond C. Stevens
Daniel Huster
Jens Meiler
Qiang Zhao
Annette G. Beck-Sickinger
Armin Buschauer
Beili Wu
Nature, 2018, 556 : 520 - 524
[30] Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease
Lundy, Fionnuala T.
El Karim, Ikhlas A.
Linden, Gerard J.
ARCHIVES OF ORAL BIOLOGY, 2009, 54 (03) : 258 - 262

← 1 2 3 4 5 →